GMTX
Gemini Therapeutics Inc

770
Mkt Cap
$679.96M
Volume
13,357.00
52W High
$77.60
52W Low
$25.60
PE Ratio
-7.86
GMTX Fundamentals
Price
$28.21
Prev Close
$27.55
Open
$28.47
50D MA
$51.07
Beta
0.77
Avg. Volume
386,830.15
EPS (Annual)
-$3.50
P/B
1.85
EV/EBITDA
-9.38
Loading...
Loading...
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel treatments for hematologic disorders. Its programs include Bitopertin, DISC-0974, and DISC-3405. The company was founded in October 2017 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Gemini Therapeutics Inc?
What is the 52-week high for Gemini Therapeutics Inc?
What is the 52-week low for Gemini Therapeutics Inc?
What is Gemini Therapeutics Inc stock price today?
What was Gemini Therapeutics Inc stock price yesterday?
What is the PE ratio of Gemini Therapeutics Inc?
What is the Price-to-Book ratio of Gemini Therapeutics Inc?
What is Gemini Therapeutics Inc's EBITDA?
What is the 50-day moving average of Gemini Therapeutics Inc?

Latest GMTX News

View
No GMTX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.